The FDA/ASCO Fellows' Day Workshop is designed to support trainees interested in drug development by providing an introduction to the U.S. Food and Drug Administration (FDA), clinical trial design, oncology drug regulatory science and the drug/device approval process. Oncology refers to solid tumors and hematologic malignancies throughout this document.
*The October 24, 2024 workshop is a hybrid experience*
Date & Time: Thursday, October 24, 2024
- 9:15 AM - 3:30 PM - Hybrid Workshop: Topics to be covered include clinical trial design, endpoints, expanded access programs, regulatory science, disease-specific considerations, and common challenges in oncology drug development.
- 2:45 PM - 3:30 PM - Optional FDA Oncology Center of Excellence (OCE) Careers Sessions: A Day in the Life of an FDA Oncologist.
Workshop Format: The workshop is a hybrid experience. Participants choose to apply for either virtual participation or in-person participation at the FDA’s White Oak campus in Silver Spring, MD, a suburb of Washington, D.C. FDA hematologists/oncologists will serve as faculty for the workshop, which features case-based panel discussions, small-group breakout sessions, and audience Question & Answer. If selected for in-person participation, ASCO will provide a reimbursement of up to $500 to defray the costs of transportation and lodging. Please note that the workshop may become fully virtual if it cannot be held in-person.
Eligibility: Oncology trainees who have completed at least 1-year of oncology subspecialty training. Preference will be given to trainees in their final year of training. Trainees in all oncology subspecialties (medical oncology, surgical oncology, gynecologic oncology, radiation oncology, pediatric oncology, etc.) are welcome to apply.
October 2024 FDA/ASCO Fellows' Day Workshop
The FDA/ASCO Fellows' Day Workshop is designed to support trainees interested in drug development by providing an introduction to the U.S. Food and Drug Administration (FDA), clinical trial design, oncology drug regulatory science and the drug/device approval process. Oncology refers to solid tumors and hematologic malignancies throughout this document.
*The October 24, 2024 workshop is a hybrid experience*
Date & Time: Thursday, October 24, 2024
- 9:15 AM - 3:30 PM - Hybrid Workshop: Topics to be covered include clinical trial design, endpoints, expanded access programs, regulatory science, disease-specific considerations, and common challenges in oncology drug development.
- 2:45 PM - 3:30 PM - Optional FDA Oncology Center of Excellence (OCE) Careers Sessions: A Day in the Life of an FDA Oncologist.
Workshop Format: The workshop is a hybrid experience. Participants choose to apply for either virtual participation or in-person participation at the FDA’s White Oak campus in Silver Spring, MD, a suburb of Washington, D.C. FDA hematologists/oncologists will serve as faculty for the workshop, which features case-based panel discussions, small-group breakout sessions, and audience Question & Answer. If selected for in-person participation, ASCO will provide a reimbursement of up to $500 to defray the costs of transportation and lodging. Please note that the workshop may become fully virtual if it cannot be held in-person.
Eligibility: Oncology trainees who have completed at least 1-year of oncology subspecialty training. Preference will be given to trainees in their final year of training. Trainees in all oncology subspecialties (medical oncology, surgical oncology, gynecologic oncology, radiation oncology, pediatric oncology, etc.) are welcome to apply.